Montelukast Supplier-Buyer Network — Trade Flow Analysis

Name: Montelukast Supplier-Buyer Trade Network Dataset — 510+ Indian Exporters, 21+ Importers, 138+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Montelukast supplier network, Montelukast buyers, pharmaceutical export India, Montelukast trade data

TransData Nexus

Montelukast

India Pharmaceutical Trade Intelligence

$168.3M510 Suppliers138 CountriesHS 30049099

ExportsIndia → UNITED STATES58.1%India → PHILIPPINES7.9%

ImportsUNITED STATES → India$7.2K MALTA → India$6.9K

#1 Buyer: AMERISOURCE HEALTH

Who Supplies Montelukast? Top Manufacturers & Buyers 2026 — MACLEODS PHARMACEUTICALS LTD Leads | TransData Nexus | TransData Nexus

1MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the first-largest Montelukast exporter from India, with a market share of 36.4% and a total export value of $61.3M across 231 shipments. Their average shipment value of $265.4K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AMERISOURCE HEALTH SERVICES — $28.4M across 107 shipments (46.4% of this supplier's total exports)

• MACLEODS PHARMA USA ,INC — $25.1M across 94 shipments (40.9% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES — $7.3M across 28 shipments (11.9% of this supplier's total exports)

• MACLEODS PHARMACEUTI — $273.9K across 1 shipments (0.4% of this supplier's total exports)

• MACLEODS PHARMA USA ,INC — $214.2K across 1 shipments (0.3% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $265.4K is 914% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

2UNICHEM LABORATORIES LIMITED

UNICHEM LABORATORIES LIMITED is the second-largest Montelukast exporter from India, with a market share of 5.2% and a total export value of $8.8M across 262 shipments. Their average shipment value of $33.7K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

UNICHEM LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• UNICHEM PHARMACEUTICALS (USA) INC — $3.0M across 89 shipments (34.1% of this supplier's total exports)

• UNICHEM PHARMACEUTICALS (USA) INC — $2.9M across 86 shipments (32.9% of this supplier's total exports)

• UNICHEM PHARMACEUTICALS (USA) INC — $2.2M across 65 shipments (24.6% of this supplier's total exports)

• UNICHEM PHARMACEUTICALS (USA) INC — $582.3K across 17 shipments (6.6% of this supplier's total exports)

• UNICHEM PHARMACEUTICALS (USA) INC — $155.8K across 5 shipments (1.8% of this supplier's total exports)

Key Insight: UNICHEM LABORATORIES LIMITED's per-shipment value of $33.7K is 29% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

3AJANTA PHARMA LIMITED

AJANTA PHARMA LIMITED is the third-largest Montelukast exporter from India, with a market share of 4.7% and a total export value of $8.0M across 128 shipments. Their average shipment value of $62.2K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

AJANTA PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• THE CATHAY DRUG CO INC — $2.6M across 41 shipments (32.1% of this supplier's total exports)

• AJANTA PHARMA PHILIPPINES INC — $2.3M across 38 shipments (29.4% of this supplier's total exports)

• THE CATHAY DRUG CO. INC — $1.3M across 20 shipments (15.9% of this supplier's total exports)

• THE CATHAY DRUG CO INC — $1.3M across 20 shipments (15.9% of this supplier's total exports)

• SHAMS AL-THURAYA CO — $523.8K across 8 shipments (6.6% of this supplier's total exports)

Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $62.2K is 138% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

4CIPLA LIMITED

CIPLA LIMITED is the fourth-largest Montelukast exporter from India, with a market share of 4.4% and a total export value of $7.4M across 92 shipments. Their average shipment value of $80.4K is above the market average of $26.2K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. BREATHEFREE LANKA PVT LTD is the dominant customer, accounting for 96.8% of this supplier's tracked business. Top customers include:

• BREATHEFREE LANKA PVT LTD — $7.2M across 89 shipments (96.8% of this supplier's total exports)

• BREATHEFREE LANKA PR — $205.3K across 3 shipments (2.8% of this supplier's total exports)

• GENERICAL S.A — $23.3K across 0 shipments (0.3% of this supplier's total exports)

• CAPITAL PHARMACY — $3.7K across 0 shipments (0.1% of this supplier's total exports)

• JDS CO LIMITED — $3.2K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $80.4K is 207% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.

5DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the fifth-largest Montelukast exporter from India, with a market share of 2.1% and a total export value of $3.5M across 219 shipments. Their average shipment value of $15.9K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.

DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DR. REDDYS LABORATORIES, INC — $1.2M across 78 shipments (35.4% of this supplier's total exports)

• DR. REDDYS LABORATORIES, INC — $843.0K across 53 shipments (24.2% of this supplier's total exports)

• DR.REDDY'S LABORATOR — $626.3K across 39 shipments (18.0% of this supplier's total exports)

• DR. REDDYS LABORATORIES, INC — $443.9K across 28 shipments (12.8% of this supplier's total exports)

• MOVIANTO UK LTD, — $332.6K across 21 shipments (9.6% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (219 shipments) at a per-shipment value of $15.9K, indicating a broad distribution network with many smaller, regular orders.

6TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the fifth-largest Montelukast exporter from India, with a market share of 1.3% and a total export value of $2.2M across 221 shipments. Their average shipment value of $10.0K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.

TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ORION CORPORATION — $676.5K across 68 shipments (30.8% of this supplier's total exports)

• TRINITY PHARMA (PTY) — $633.0K across 64 shipments (28.8% of this supplier's total exports)

• AL FARABI PHARMACY — $378.2K across 38 shipments (17.2% of this supplier's total exports)

• PHARMA DYNAMICS (PTY — $264.4K across 27 shipments (12.0% of this supplier's total exports)

• HEUMANN PHARMA GMBH — $247.7K across 25 shipments (11.3% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD operates with high shipment frequency (221 shipments) at a per-shipment value of $10.0K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Montelukast imports from India, with a total trade value of $97.8M across 454 shipments — representing a 58.1% share of all Montelukast exports. The average shipment value of $215.4K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.

Named Montelukast importers in United States: AMERISOURCE HEALTH SERVICES is the largest buyer, accounting for 29.9% ($29.2M) of this market's total imports.

• AMERISOURCE HEALTH SERVICES — $29.2M (29.9% of United States's total)

• MACLEODS PHARMA USA ,INC — $25.3M (25.9% of United States's total)

• UNICHEM PHARMACEUTICALS (USA) INC. — $6.3M (6.5% of United States's total)

Key Insight: United States's per-shipment average of $215.4K (723% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Montelukast imports from India.

Primary Market

Secondary Market

2Philippines

Philippines ranks as the second-largest destination for Montelukast imports from India, with a total trade value of $13.3M across 29 shipments — representing a 7.9% share of all Montelukast exports. The average shipment value of $459.1K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Montelukast importers in Philippines: THE CATHAY DRUG CO. INC is the largest buyer, accounting for 31.2% ($4.2M) of this market's total imports.

• THE CATHAY DRUG CO. INC — $4.2M (31.2% of Philippines's total)

• THE CATHAY DRUG CO INC — $2.6M (19.2% of Philippines's total)

• AJANTA PHARMA PHILIPPINES INC — $2.3M (17.6% of Philippines's total)

Key Insight: Philippines's per-shipment average of $459.1K (1654% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Montelukast imports from India.

Primary Market

Secondary Market

3Sri Lanka

Sri Lanka ranks as the third-largest destination for Montelukast imports from India, with a total trade value of $8.5M across 67 shipments — representing a 5.1% share of all Montelukast exports. The average shipment value of $127.5K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Montelukast importers in Sri Lanka: BREATHEFREE LANKA PVT LTD is the largest buyer, accounting for 91.3% ($7.8M) of this market's total imports.

• BREATHEFREE LANKA PVT LTD — $7.8M (91.3% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $127.5K (387% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Montelukast imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Montelukast imports from India, with a total trade value of $8.1M across 115 shipments — representing a 4.8% share of all Montelukast exports. The average shipment value of $70.3K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Montelukast importers in United Kingdom: ACCORD UK is the largest buyer, accounting for 16.0% ($1.3M) of this market's total imports.

• ACCORD UK — $1.3M (16.0% of United Kingdom's total)

• GLENMARK PHARMACEUTICALS EUROPE LTD — $1.2M (15.3% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $70.3K (169% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Montelukast imports from India.

Primary Market

Secondary Market

5South Africa

South Africa ranks as the fifth-largest destination for Montelukast imports from India, with a total trade value of $6.7M across 0 shipments — representing a 4.0% share of all Montelukast exports. The average shipment value of $6.7M is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: South Africa's per-shipment average of $6.7M (25525% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Montelukast imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Montelukast.
2.Flow Mapping: 510 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 6,431 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 138 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

6,431 Verified Shipments

510 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Montelukast

Montelukast

Who Supplies Montelukast? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Montelukast? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Montelukast Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MACLEODS PHARMACEUTICALS LTD

2UNICHEM LABORATORIES LIMITED

3AJANTA PHARMA LIMITED

4CIPLA LIMITED

5DR.REDDY'S LABORATORIES LTD

6TORRENT PHARMACEUTICALS LTD

From Indian Factories to Global Pharmacies — How Montelukast Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Montelukast Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Philippines

3Sri Lanka

4United Kingdom

5South Africa

People Also Ask — Montelukast Supplier & Trade Network

Montelukast Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology